Non-high-density Lipoprotein Cholesterol for Secondary Prevention after Minor Stroke
- PMID: 39551491
- PMCID: PMC11802247
- DOI: 10.5551/jat.ED272
Non-high-density Lipoprotein Cholesterol for Secondary Prevention after Minor Stroke
Similar articles
-
[The association of lipid profile and bleeding in patients with minor stroke or transient ischemic attack on antiplatelet therapy: subgroup analysis of CHANCE].Zhonghua Nei Ke Za Zhi. 2018 Oct 1;57(10):723-730. doi: 10.3760/cma.j.issn.0578-1426.2018.10.006. Zhonghua Nei Ke Za Zhi. 2018. PMID: 30293332 Clinical Trial. Chinese.
-
Non-high-density lipoprotein cholesterol: an important predictor of stroke and diabetes-related mortality in Japanese elderly diabetic patients.Geriatr Gerontol Int. 2012 Apr;12 Suppl 1:18-28. doi: 10.1111/j.1447-0594.2011.00809.x. Geriatr Gerontol Int. 2012. PMID: 22435937 Clinical Trial.
-
Predictive value of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio for the prevention of stroke recurrence in Japanese patients treated with rosuvastatin.Clin Drug Investig. 2012 Aug 1;32(8):513-21. doi: 10.1007/BF03261902. Clin Drug Investig. 2012. PMID: 22741749
-
Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.Curr Diab Rep. 2019 Nov 21;19(12):146. doi: 10.1007/s11892-019-1246-y. Curr Diab Rep. 2019. PMID: 31754844 Review.
-
Role of non-high-density lipoprotein cholesterol in prevention of cardiovascular disease: updated evidence from clinical trials.Curr Opin Cardiol. 2003 Nov;18(6):503-9. doi: 10.1097/00001573-200311000-00012. Curr Opin Cardiol. 2003. PMID: 14597892 Review.
References
-
- Rota E, Morelli N, Immovilli P, Cerasti D, Zini A and Guidetti D: “Minor” stroke: not a minor, still open question. J Thromb Thrombolysis, 2020; 49: 132-135 - PubMed
-
- Lim A, Ma H, Johnston SC, Singhal S, Muthusamy S, Wang Y, Pan Y, Coutts SB, Hill MD, Ois A, Kapral MK, Knoflach M, Woodhouse LJ, Bath PM and Phan TG: Ninety-Day Stroke Recurrence in Minor Stroke: Systematic Review and Meta-Analysis of Trials and Observational Studies. J Am Heart Assoc, 2024; 13: e032471 - PMC - PubMed
-
- Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC, Jr., Turan TN and Williams LS: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke, 2021; 52: e364-e467 - PubMed
-
- Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Bejot Y, Cabrejo L, Cha JK, Ducrocq G, Giroud M, Guidoux C, Hobeanu C, Kim YJ, Lapergue B, Lavallee PC, Lee BC, Lee KB, Leys D, Mahagne MH, Meseguer E, Nighoghossian N, Pico F, Samson Y, Sibon I, Steg PG, Sung SM, Touboul PJ, Touze E, Varenne O, Vicaut E, Yelles N, Bruckert E and Treat Stroke to Target I: A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke. N Engl J Med, 2020; 382: 9
-
- Gao Y, Chen W, Pan Y, Jing J, Wang C, Johnston SC, Amarenco P, Bath PM, Jiang L, Yang Y, Wang T, Han S, Meng X, Lin J, Zhao X, Liu L, Zhao J, Li Y, Zang Y, Zhang S, Yang H, Yang J, Wang Y, Li D, Wang Y, Liu D, Kang G, Wang Y and Wang Y: Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke. N Engl J Med, 2023; 389: 2413-2424 - PubMed